St. Jude Medical (STJ) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
St. Jude Medical Reports Third Quarter 2016 Results
October 19, 2016 7:15 AM EDTST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today reported sales and net earnings for the third quarter ended October 1, 2016.
Third quarter 2016 highlights:
Net sales of $1.499 billion increased 12 percent as reported, or 2 percent on a comparable constant currency basis. International sales increased 13 percent as reported or 8 percent on a comparable constant currency basis, where a full portfolio of products is available. Neuromodulation sales increased 17 percent both as reported and on a constant currency... More